Johnson & Johnson Halts COVID-19 Vaccine Tests After An ‘Unexplained Illness’
Image via josefkubes / Shutterstock.com
Johnson & Johnson had to temporarily stop the final stage of its COVID-19 vaccine trial after a volunteer was discovered with an “unexplained illness.”
It is unclear if the unidentified condition was caused by the phase-three clinical experiment. Therefore, it is required for Johnson & Johnson-owned Janssen Research & Development to investigate the participant’s condition before carrying on with the trial.
The JNJ-78436735 vaccine was delivered through a harmless virus called Adenovirus 26, which is uncommon so most people have yet to develop an immunity to it.
The participant’s ailment will be observed and assessed by an independent Data Safety Monitoring Board, as well as Johnson & Johnson’s clinical and safety practitioners.
The company did not reveal the participant’s information nor the type of illness. “We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” Johnson & Johnson’s said in a statement.
The company began enrolling candidates back on 23 September 2020 and gathered around 60,000 volunteers for the trial.
[via USA Today, cover image via josefkubes / Shutterstock.com]
Also check out these recent news
